Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Results
Abstract
All sarilumab studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchSarilumabSarilumab (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)

Sancho-López et al., Infectious Diseases and Therapy, doi:10.1007/s40121-021-00543-2, SARTRE
Oct 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Mortality -3% Improvement Relative Risk ICU admission 30% Brescia ≥ 2 -14% Brescia ≥ 3 at any moment.. -3% Brescia ≥ 3 at any mo.. (b) -3% primary Sarilumab  SARTRE  LATE TREATMENT  RCT Is late treatment with sarilumab beneficial for COVID-19? RCT 201 patients in Spain (August 2020 - March 2021) Lower ICU admission with sarilumab (not stat. sig., p=0.5) c19early.org Sancho-López et al., Infectious Diseas.., Oct 2021 Favorssarilumab Favorscontrol 0 0.5 1 1.5 2+
RCT 201 hospitalized COVID-19 pneumonia patients under standard oxygen therapy in Spain showing no significant difference with sarilumab treatment.
risk of death, 3.0% higher, RR 1.03, p = 0.98, treatment 2 of 99 (2.0%), control 2 of 102 (2.0%), adjusted per study, day 28.
risk of ICU admission, 30.0% lower, RR 0.70, p = 0.50, treatment 7 of 99 (7.1%), control 10 of 102 (9.8%), NNT 37, adjusted per study, day 28.
Brescia ≥ 2, 14.0% higher, RR 1.14, p = 0.66, treatment 40 of 99 (40.4%), control 40 of 102 (39.2%), adjusted per study, day 28.
Brescia ≥ 3 at any moment, 3.0% higher, RR 1.03, p = 0.94, treatment 40 of 99 (40.4%), control 40 of 102 (39.2%), adjusted per study, day 28.
Brescia ≥ 3 at any moment, 3.0% higher, RR 1.03, p = 0.94, treatment 40 of 99 (40.4%), control 40 of 102 (39.2%), adjusted per study, day 14, primary outcome.
Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates
Sancho-López et al., 17 Oct 2021, Randomized Controlled Trial, Spain, peer-reviewed, median age 60.0, 22 authors, study period 4 August, 2020 - 23 March, 2021, SARTRE trial. Contact: asancho.hpth@gmail.com, bruizantoran@gmail.com.
This PaperSarilumabAll
Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)
Aránzazu Sancho-López, Antonio F Caballero-Bermejo, Belén Ruiz-Antorán, Elena Múñez Rubio, Mercedes García Gasalla, Juan Buades, Marta González Rozas, María López Veloso, Ana Muñoz Gómez, Ana Cuenca Abarca, Pedro Durán Del Campo, Fátima Ibáñez, Alberto Díaz De Santiago, Yolanda Romero, Jorge Calderón, Ilduara Pintos, Adrián Ferre Beltrán, Gustavo Centeno Soto, José Campos, Antonio Ramos Martínez, Cristina Avendaño-Solá, Ana Fernández Cruz, Aránzazu Sancho-López, Antonio F Bermejo Caballero, Belén Ruiz-Antorán, Ana Fernández-Cruz, Elena Múñez, Antonio Ramos Martínez, Cristina Avendaño-Solá, Elena Diago-Sempere, Pedro Durán Del Campo, Fátima Ibáñez, Alberto Díaz De Santiago, Yolanda Romero, Jorge Calderón Parra, Ilduara Pinto, Gustavo Centeno, Concepción Payares, Almudena Ramírez-García, Laura Javaloyes, María De La Encina Higuera, Rocío Layunta Acero, Laura Vicente, Paloma Rodríguez Araque, Piedad Ussetti-Gil, Rosa Malo De Molina, Andrea Trisan Alonso, Manuel Valle Falconés, Fernando Montoya, María Luisa Jiménezjiménez, Laura Ferrer, Jorge Ramos, Alejandro Junco, José Campos, Alejandro Callejas Díaz, Sara De La Fuente Moral, Pedro Laguna, Gema Vázquez Contreras, Alejandro Muñoz Serrano, Isolina Baños Pérez, Víctor Moreno Torres-Concha, Alfonso Ángel-Moreno Maroto, Esther Montero Hernández, Mª Carmen Máinez Saíz, Mª Cruz Carreño Hernández, Rosa Muñoz De Benito, Susana Mellor Pita, Pablo Tutor De Ureta, Miriam Aguilar Pérez, Gema Díaz Nuevo, Christian García Fadul, Beatriz Jara Chinarro, Rosalía Laporta Hernández, María Lázaro De La Fuentecarrasco, Cristina López García Gallo, Patricia Mínguez Clemente, Roberto Carabias Arca, Marta Erro Iribarreniribarren, Ane Andrés Eisenhofer, Itziar Diego Yagüe, Ignacio Donate Velascovelasco, Gabriela Escudero López, Esther Expósito Palomo, Amy Galán Gómez, Sonia García Prieto, Javier Gómez Irusta, Edith Vanessa Gutiérrez Abreu, Isabel Gutiérrez Martín, Ángela Gutiérrez Rojas, Andrea Gutiérrez Villanueva, Jesús Herráiz Jiménez, María Martínez Urbistondo, Fernando Martínez Vara, Patricia Mills Sánchez, Alberto Mora Vargas, Ignacio Morrás De La Torre, Enrique Sánchez Chica, Ángela Valencia Alijo, Jos Manuel Vázquez Comendador, Ana Arias Milla, Juan Antonio Vargas Núñez, Valentín Cuervas-Mons Martínez, Carmen Cubero, Celia Rodríguez Olleros, Elvira Ramos Carral, Yale Tung, Mercedes García Gasalla, Adrián Ferré Beltrán, Pere Ventayol Bosch, Juana Maria Ferrer Balaguer, Francisca Artigues Serra, Alfredo Manuel Santos Pinheiro, Helem H Rueda Vilchez, Antonio Palomero, Ana Muñoz Gómez, Francisco Javier Teigell Muñoz, Elena García Guijarro, Francisco García Sánchez, José Antonio Melero Bermejo, María Mateos González, Aitor Olmo Sánchez, Juan Vicente De La Sota, Elena Matilla, María López Veloso, Julio Barraza Vengoechea, Enrique Iglesias Julián, Ana Marta Espeja Martínez, Fernando Orza García, Luis Buzón Martin, Marta Ubeira Iglesias, Ana Belén Cuenca Abarca, Pedro Gargantilla Madera, Luis Miguel Belda Bilbao, Juan Francisco Montoro Lara, Almudena García Tobaruela, Francisco Javier Montero Jiménez, Silvana Emilise Fiorante, Susana Sánchez Suárez, Carolina Aguilar Casado, Carla Ruth Mejía Medina, Pablo Carrasco Lara, María Isabel Barcia Martín, Mercedes García Gimeno, Juan Buades, Inés Losada, Aroa Villoslada, Salvador Pons, Monserrat Vilanova, Adrián Rodríguez, Eugenia Cisneros Barroso, Mónica Sanz, Marta González Rozas, Pablo Bachiller Luque, Ana Carrero Gras, Raquel Coloma Peral, Mª Teresa Criado Illana, Eva Ferreira Pasospasos, Laura Martin Ventura, Javier Moreno Palomares, Fuencisla Gómez Ruiz
Infectious Diseases and Therapy, doi:10.1007/s40121-021-00543-2
Introduction: SARS-CoV-2 pneumonia is often associated with hyper-inflammation. The cytokine-storm-like is one of the targets of current therapies for coronavirus disease 2019 . High Interleukin-6 (IL6) blood levels have been identified in severe COVID-19 disease, but there are still uncertainties regarding the actual role of anti-IL6 antagonists in COVID-19 management. Our hypothesis was that the use of sarilumab plus corticosteroids at an early stage of the hyper-inflammatory syndrome would be beneficial and prevent progression to acute respiratory distress syndrome (ARDS). Methods: We randomly assigned (in a 1:1 ratio) COVID-19 pneumonia hospitalized patients under standard oxygen therapy and laboratory evidence of hyper-inflammation to receive sarilumab plus usual care (experimental group) or Antonio F.
References
Bermejo, Ruiz-Antora ´n, Cruz, Sempere, Dı ´az et al., Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial, Trials
Cantini, Goletti, Petrone, Fard, Niccoli et al., Immune therapy, or antiviral therapy, or both for covid-19: a systematic review, Drugs, doi:10.1007/s40265-020-01421-w
Duca, Piva, Foca, Latronico, Rizzi, Calculated decisions: Brescia-COVID Respiratory Severity Scale (BCRSS)/algorithm, Emerg Med Pract
Fajgenbaum, June, Cytokine storm, N Engl J Med, doi:10.1056/NEJMra2026131
Fu, Cheng, Wu, Understanding SARS-CoV-2mediated inflammatory responses: from mechanisms to potential therapeutic tools, Virol Sin, doi:10.1007/s12250-020-00207-4
Hermine, Mariette, Tharaux, Resche-Rigon, Porcher et al., Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia, JAMA Intern Med
Investigators, Derde, Effectiveness of tocilizumab, sarilumab, and anakinra for critically ill patients with COVID-19 the REMAP-CAP COVID-19 immune modulation therapy domain randomized clinical trial, medRxiv, doi:10.1101/2021.06.18.21259133v2
Investigators, Gordon, Mouncey, Al-Beidh, Rowan et al., Interleukin-6 receptor antagonists in critically ill patients with Covid-19, N Engl J Med
Jang, Rhee, Wi, Jung, Viral kinetics of SARS-CoV-2 over the preclinical, clinical, and postclinical period, Int J Infect Dis
Lescure, Honda, Fowler, Lazar, Shi et al., Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial, Lancet Respir Med
Moore, June, Cytokine release syndrome in severe COVID-19, Science, doi:10.1126/science.abb8925
Rosas, Bra ¨u, Waters, Go, Hunter et al., Tocilizumab in hospitalized patients with severe Covid-19 pneumonia, N Engl J Med, doi:10.1056/NEJMoa2028700
Rubin, Longo, Baden, Interleukin-6 receptor inhibition in Covid-19: cooling the inflammatory soup, N Engl J Med
Ruiz-Antora ´n, ´pez, Torres, Moreno-Torres, De et al., Combination of tocilizumab and steroids to improve mortality in patients with severe covid-19 infection: a Spanish, multicenter, cohort study, Infect Dis Ther, doi:10.1007/s40121-020-00373-8
Salama, Han, Yau, Reiss, Kramer et al., Tocilizumab in patients hospitalized with Covid-19 pneumonia, N Engl J Med, doi:10.1056/NEJMoa2030340
Shankar-Hari, Vale, Godolphin, Fisher, Higgins et al., Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19, JAMA
Stone, Frigault, Serling-Boyd, Fernandes, Harvey et al., Efficacy of tocilizumab in patients hospitalized with Covid-19, N Engl J Med, doi:10.1056/NEJMoa2028836
Veiga, Prats, Farias, Rosa, Dourado et al., Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial, BMJ, doi:10.1136/bmj.n84
Who, Therapeutics and COVID19: living guidance
{ 'indexed': {'date-parts': [[2024, 9, 9]], 'date-time': '2024-09-09T17:18:33Z', 'timestamp': 1725902313398}, 'reference-count': 22, 'publisher': 'Springer Science and Business Media LLC', 'issue': '4', 'license': [ { 'start': { 'date-parts': [[2021, 10, 17]], 'date-time': '2021-10-17T00:00:00Z', 'timestamp': 1634428800000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0'}, { 'start': { 'date-parts': [[2021, 10, 17]], 'date-time': '2021-10-17T00:00:00Z', 'timestamp': 1634428800000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0'}], 'funder': [ { 'DOI': '10.13039/501100013412', 'name': 'Sanofi España', 'doi-asserted-by': 'publisher', 'id': [{'id': '10.13039/501100013412', 'id-type': 'DOI', 'asserted-by': 'publisher'}]}, { 'name': 'Biomedical Research Foundation of the Puerta de Hierro Majadahonda University ' 'Hospital'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 12]]}, 'DOI': '10.1007/s40121-021-00543-2', 'type': 'journal-article', 'created': { 'date-parts': [[2021, 10, 17]], 'date-time': '2021-10-17T17:06:20Z', 'timestamp': 1634490380000}, 'page': '2735-2748', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 18, 'title': 'Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III ' 'Clinical Trial (SARTRE Study)', 'prefix': '10.1007', 'volume': '10', 'author': [ {'given': 'Aránzazu', 'family': 'Sancho-López', 'sequence': 'first', 'affiliation': []}, { 'given': 'Antonio F.', 'family': 'Caballero-Bermejo', 'sequence': 'additional', 'affiliation': []}, { 'ORCID': 'http://orcid.org/0000-0002-2020-9077', 'authenticated-orcid': False, 'given': 'Belén', 'family': 'Ruiz-Antorán', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Múñez Rubio', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mercedes', 'family': 'García Gasalla', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan', 'family': 'Buades', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marta', 'family': 'González Rozas', 'sequence': 'additional', 'affiliation': []}, {'given': 'María', 'family': 'López Veloso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana', 'family': 'Muñoz Gómez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana', 'family': 'Cuenca Abarca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pedro', 'family': 'Durán del Campo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fátima', 'family': 'Ibáñez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alberto', 'family': 'Díaz de Santiago', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yolanda', 'family': 'Romero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jorge', 'family': 'Calderón', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ilduara', 'family': 'Pintos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adrián', 'family': 'Ferre Beltrán', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gustavo', 'family': 'Centeno Soto', 'sequence': 'additional', 'affiliation': []}, {'given': 'José', 'family': 'Campos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antonio', 'family': 'Ramos Martínez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cristina', 'family': 'Avendaño-Solá', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana', 'family': 'Fernández Cruz', 'sequence': 'additional', 'affiliation': []}, {'name': 'the SARTRE-Study Group', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aránzazu', 'family': 'Sancho-López', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Antonio F. Bermejo', 'family': 'Caballero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Belén', 'family': 'Ruiz-Antorán', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana', 'family': 'Fernández-Cruz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Múñez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antonio', 'family': 'Ramos Martínez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Cristina', 'family': 'Avendaño-Solá', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Diago-Sempere', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pedro Durán', 'family': 'del Campo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fátima', 'family': 'Ibáñez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alberto Díaz', 'family': 'de Santiago', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yolanda', 'family': 'Romero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jorge Calderón', 'family': 'Parra', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ilduara', 'family': 'Pinto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gustavo', 'family': 'Centeno', 'sequence': 'additional', 'affiliation': []}, {'given': 'Concepción', 'family': 'Payares', 'sequence': 'additional', 'affiliation': []}, {'given': 'Almudena', 'family': 'Ramírez-García', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Javaloyes', 'sequence': 'additional', 'affiliation': []}, { 'given': 'María', 'family': 'de la Encina Higuera', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rocío Layunta', 'family': 'Acero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Vicente', 'sequence': 'additional', 'affiliation': []}, {'given': 'Paloma Rodríguez', 'family': 'Araque', 'sequence': 'additional', 'affiliation': []}, {'given': 'Piedad', 'family': 'Ussetti-Gil', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rosa Malo', 'family': 'de Molina', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrea Trisan', 'family': 'Alonso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Manuel Valle', 'family': 'Falconés', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fernando', 'family': 'Montoya', 'sequence': 'additional', 'affiliation': []}, { 'given': 'María Luisa', 'family': 'JiménezJiménez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura', 'family': 'Ferrer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jorge', 'family': 'Ramos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alejandro', 'family': 'Junco', 'sequence': 'additional', 'affiliation': []}, {'given': 'José', 'family': 'Campos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alejandro Callejas', 'family': 'Díaz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sara', 'family': 'de la Fuente Moral', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pedro', 'family': 'Laguna', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gema Vázquez', 'family': 'Contreras', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alejandro Muñoz', 'family': 'Serrano', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isolina Baños', 'family': 'Pérez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Víctor Moreno', 'family': 'Torres-Concha', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Alfonso Ángel-Moreno', 'family': 'Maroto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Esther Montero', 'family': 'Hernández', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mª Carmen Máinez', 'family': 'Saíz', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Mª Cruz Carreño', 'family': 'Hernández', 'sequence': 'additional', 'affiliation': []}, {'given': 'Rosa Muñoz', 'family': 'de Benito', 'sequence': 'additional', 'affiliation': []}, {'given': 'Susana Mellor', 'family': 'Pita', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pablo Tutor', 'family': 'de Ureta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Miriam Aguilar', 'family': 'Pérez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gema Díaz', 'family': 'Nuevo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Christian García', 'family': 'Fadul', 'sequence': 'additional', 'affiliation': []}, {'given': 'Beatriz Jara', 'family': 'Chinarro', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Rosalía Laporta', 'family': 'Hernández', 'sequence': 'additional', 'affiliation': []}, { 'given': 'María Lázaro', 'family': 'de la FuenteCarrasco', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Cristina López García', 'family': 'Gallo', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Patricia Mínguez', 'family': 'Clemente', 'sequence': 'additional', 'affiliation': []}, {'given': 'Roberto Carabias', 'family': 'Arca', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Marta Erro', 'family': 'IribarrenIribarren', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ane Andrés', 'family': 'Eisenhofer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Itziar Diego', 'family': 'Yagüe', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Ignacio Donate', 'family': 'VelascoVelasco', 'sequence': 'additional', 'affiliation': []}, {'given': 'Gabriela Escudero', 'family': 'López', 'sequence': 'additional', 'affiliation': []}, {'given': 'Esther Expósito', 'family': 'Palomo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Amy Galán', 'family': 'Gómez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Sonia García', 'family': 'Prieto', 'sequence': 'additional', 'affiliation': []}, {'given': 'Javier Gómez', 'family': 'Irusta', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Edith Vanessa Gutiérrez', 'family': 'Abreu', 'sequence': 'additional', 'affiliation': []}, {'given': 'Isabel Gutiérrez', 'family': 'Martín', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ángela Gutiérrez', 'family': 'Rojas', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Andrea Gutiérrez', 'family': 'Villanueva', 'sequence': 'additional', 'affiliation': []}, {'given': 'Jesús Herráiz', 'family': 'Jiménez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'María Martínez', 'family': 'Urbistondo', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fernando Martínez', 'family': 'Vara', 'sequence': 'additional', 'affiliation': []}, {'given': 'Patricia Mills', 'family': 'Sánchez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Alberto Mora', 'family': 'Vargas', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Ignacio Morrás', 'family': 'de la Torre', 'sequence': 'additional', 'affiliation': []}, {'given': 'Enrique Sánchez', 'family': 'Chica', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ángela Valencia', 'family': 'Alijo', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Jos Manuel Vázquez', 'family': 'Comendador', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana Arias', 'family': 'Milla', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Juan Antonio Vargas', 'family': 'Núñez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Valentín Cuervas-Mons', 'family': 'Martínez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carmen', 'family': 'Cubero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Celia Rodríguez', 'family': 'Olleros', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elvira Ramos', 'family': 'Carral', 'sequence': 'additional', 'affiliation': []}, {'given': 'Yale', 'family': 'Tung', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mercedes García', 'family': 'Gasalla', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adrián Ferré', 'family': 'Beltrán', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pere Ventayol', 'family': 'Bosch', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Juana Maria Ferrer', 'family': 'Balaguer', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francisca Artigues', 'family': 'Serra', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Alfredo Manuel Santos', 'family': 'Pinheiro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Helem H. Rueda', 'family': 'Vilchez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Antonio', 'family': 'Palomero', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana Muñoz', 'family': 'Gómez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Francisco Javier Teigell', 'family': 'Muñoz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena García', 'family': 'Guijarro', 'sequence': 'additional', 'affiliation': []}, {'given': 'Francisco García', 'family': 'Sánchez', 'sequence': 'additional', 'affiliation': []}, { 'given': 'José Antonio Melero', 'family': 'Bermejo', 'sequence': 'additional', 'affiliation': []}, {'given': 'María Mateos', 'family': 'González', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aitor Olmo', 'family': 'Sánchez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan Vicente', 'family': 'de la Sota', 'sequence': 'additional', 'affiliation': []}, {'given': 'Elena', 'family': 'Matilla', 'sequence': 'additional', 'affiliation': []}, {'given': 'María López', 'family': 'Veloso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Julio Barraza', 'family': 'Vengoechea', 'sequence': 'additional', 'affiliation': []}, {'given': 'Enrique Iglesias', 'family': 'Julián', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Ana Marta Espeja', 'family': 'Martínez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fernando Orza', 'family': 'García', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luis Buzón', 'family': 'Martin', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marta Ubeira', 'family': 'Iglesias', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana Belén Cuenca', 'family': 'Abarca', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pedro Gargantilla', 'family': 'Madera', 'sequence': 'additional', 'affiliation': []}, {'given': 'Luis Miguel Belda', 'family': 'Bilbao', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Juan Francisco Montoro', 'family': 'Lara', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Almudena García', 'family': 'Tobaruela', 'sequence': 'additional', 'affiliation': []}, { 'given': 'Francisco Javier Montero', 'family': 'Jiménez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Silvana Emilise', 'family': 'Fiorante', 'sequence': 'additional', 'affiliation': []}, {'given': 'Susana Sánchez', 'family': 'Suárez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carolina Aguilar', 'family': 'Casado', 'sequence': 'additional', 'affiliation': []}, {'given': 'Carla Ruth Mejía', 'family': 'Medina', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pablo Carrasco', 'family': 'Lara', 'sequence': 'additional', 'affiliation': []}, { 'given': 'María Isabel Barcia', 'family': 'Martín', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mercedes García', 'family': 'Gimeno', 'sequence': 'additional', 'affiliation': []}, {'given': 'Juan', 'family': 'Buades', 'sequence': 'additional', 'affiliation': []}, {'given': 'Inés', 'family': 'Losada', 'sequence': 'additional', 'affiliation': []}, {'given': 'Aroa', 'family': 'Villoslada', 'sequence': 'additional', 'affiliation': []}, {'given': 'Salvador', 'family': 'Pons', 'sequence': 'additional', 'affiliation': []}, {'given': 'Monserrat', 'family': 'Vilanova', 'sequence': 'additional', 'affiliation': []}, {'given': 'Adrián', 'family': 'Rodríguez', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eugenia Cisneros', 'family': 'Barroso', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mónica', 'family': 'Sanz', 'sequence': 'additional', 'affiliation': []}, {'given': 'Marta González', 'family': 'Rozas', 'sequence': 'additional', 'affiliation': []}, {'given': 'Pablo Bachiller', 'family': 'Luque', 'sequence': 'additional', 'affiliation': []}, {'given': 'Ana Carrero', 'family': 'Gras', 'sequence': 'additional', 'affiliation': []}, {'given': 'Raquel Coloma', 'family': 'Peral', 'sequence': 'additional', 'affiliation': []}, {'given': 'Mª Teresa Criado', 'family': 'Illana', 'sequence': 'additional', 'affiliation': []}, {'given': 'Eva Ferreira', 'family': 'PasosPasos', 'sequence': 'additional', 'affiliation': []}, {'given': 'Laura Martin', 'family': 'Ventura', 'sequence': 'additional', 'affiliation': []}, {'given': 'Javier Moreno', 'family': 'Palomares', 'sequence': 'additional', 'affiliation': []}, {'given': 'Fuencisla Gómez', 'family': 'Ruiz', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 10, 17]]}, 'reference': [ { 'issue': '6490', 'key': '543_CR1', 'doi-asserted-by': 'publisher', 'first-page': '473', 'DOI': '10.1126/science.abb8925', 'volume': '368', 'author': 'JB Moore', 'year': '2020', 'unstructured': 'Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science ' '(80-). 2020;368(6490):473–4. https://doi.org/10.1126/science.abb8925.', 'journal-title': 'Science (80-)'}, { 'key': '543_CR2', 'doi-asserted-by': 'publisher', 'first-page': '561', 'DOI': '10.1016/j.ijid.2020.10.099', 'volume': '102', 'author': 'S Jang', 'year': '2021', 'unstructured': 'Jang S, Rhee J-Y, Wi YM, Jung BK. Viral kinetics of SARS-CoV-2 over the ' 'preclinical, clinical, and postclinical period. Int J Infect Dis. ' '2021;102:561–5.', 'journal-title': 'Int J Infect Dis'}, { 'issue': '18', 'key': '543_CR3', 'doi-asserted-by': 'publisher', 'first-page': '1929', 'DOI': '10.1007/s40265-020-01421-w', 'volume': '80', 'author': 'F Cantini', 'year': '2020', 'unstructured': 'Cantini F, Goletti D, Petrone L, Najafi Fard S, Niccoli L, Foti R. ' 'Immune therapy, or antiviral therapy, or both for covid-19: a systematic ' 'review. Drugs. 2020;80(18):1929–46. ' 'https://doi.org/10.1007/s40265-020-01421-w.', 'journal-title': 'Drugs'}, { 'issue': '3', 'key': '543_CR4', 'doi-asserted-by': 'publisher', 'first-page': '266', 'DOI': '10.1007/s12250-020-00207-4', 'volume': '35', 'author': 'Y Fu', 'year': '2020', 'unstructured': 'Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory ' 'responses: from mechanisms to potential therapeutic tools. Virol Sin. ' '2020;35(3):266–71. https://doi.org/10.1007/s12250-020-00207-4.', 'journal-title': 'Virol Sin'}, { 'issue': '23', 'key': '543_CR5', 'doi-asserted-by': 'publisher', 'first-page': '2255', 'DOI': '10.1056/NEJMra2026131', 'volume': '383', 'author': 'DC Fajgenbaum', 'year': '2020', 'unstructured': 'Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. ' '2020;383(23):2255–73. https://doi.org/10.1056/NEJMra2026131.', 'journal-title': 'N Engl J Med'}, { 'issue': '1', 'key': '543_CR6', 'doi-asserted-by': 'publisher', 'first-page': '347', 'DOI': '10.1007/s40121-020-00373-8', 'volume': '10', 'author': 'B Ruiz-Antorán', 'year': '2021', 'unstructured': 'Ruiz-Antorán B, Sancho-López A, Torres F, Moreno-Torres V, de ' 'Pablo-López I, García-López P, et al. Combination of tocilizumab and ' 'steroids to improve mortality in patients with severe covid-19 ' 'infection: a Spanish, multicenter, cohort study. Infect Dis Ther. ' '2021;10(1):347–62. https://doi.org/10.1007/s40121-020-00373-8.', 'journal-title': 'Infect Dis Ther'}, { 'issue': '16', 'key': '543_CR7', 'doi-asserted-by': 'publisher', 'first-page': '1491', 'DOI': '10.1056/NEJMoa2100433', 'volume': '384', 'author': 'AC Gordon', 'year': '2021', 'unstructured': 'REMAP-CAP Investigators, Gordon AC, Mouncey PR, Al-Beidh F, Rowan KM, ' 'Nichol AD, et al. Interleukin-6 receptor antagonists in critically ill ' 'patients with Covid-19. N Engl J Med. 2021;384(16):1491–502.', 'journal-title': 'N Engl J Med'}, { 'issue': '10285', 'key': '543_CR8', 'doi-asserted-by': 'publisher', 'first-page': '1637', 'DOI': '10.1016/S0140-6736(21)00676-0', 'volume': '397', 'author': 'RECOVERY Collaborative Group', 'year': '2021', 'unstructured': 'RECOVERY Collaborative Group. Tocilizumab in patients admitted to ' 'hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, ' 'platform trial. Lancet (London, England). 2021;397(10285):1637–45.', 'journal-title': 'Lancet (London, England)'}, { 'issue': '6', 'key': '543_CR9', 'doi-asserted-by': 'publisher', 'first-page': '499', 'DOI': '10.1001/jama.2021.11330', 'volume': '326', 'author': 'M Shankar-Hari', 'year': '2021', 'unstructured': 'Shankar-Hari M, Claire L, Vale P, Godolphin PJ, Fisher D, Higgins JPT, ' 'Spiga F, et al. Association between administration of IL-6 antagonists ' 'and mortality among patients hospitalized for COVID-19. JAMA. ' '2021;326(6):499–518.', 'journal-title': 'JAMA.'}, { 'key': '543_CR10', 'unstructured': 'WHO. Therapeutics and COVID19: living guidance. 2021. ' 'https://app.magicapp.org/#/guideline/nBkO1E/section/LrV7OL. Accessed 01 ' 'Sep 2021.'}, { 'key': '543_CR11', 'doi-asserted-by': 'publisher', 'DOI': '10.1101/2021.06.18.21259133v2', 'author': 'TR-C Investigators', 'year': '2021', 'unstructured': 'Investigators TR-C, Derde LPG. Effectiveness of tocilizumab, sarilumab, ' 'and anakinra for critically ill patients with COVID-19 the REMAP-CAP ' 'COVID-19 immune modulation therapy domain randomized clinical trial. ' 'medRxiv. 2021. https://doi.org/10.1101/2021.06.18.21259133v2.', 'journal-title': 'medRxiv'}, { 'key': '543_CR12', 'unstructured': 'National Institutes of Health. COVID-19 Treatment Guidelines Panel. ' 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. 2021. ' 'https://www.covid19treatmentguidelines.nih.gov/. Accessed 01 Sep 2021.'}, { 'issue': '16', 'key': '543_CR13', 'doi-asserted-by': 'publisher', 'first-page': '1564', 'DOI': '10.1056/NEJMe2103108', 'volume': '384', 'author': 'EJ Rubin', 'year': '2021', 'unstructured': 'Rubin EJ, Longo DL, Baden LR. Interleukin-6 receptor inhibition in ' 'Covid-19: cooling the inflammatory soup. N Engl J Med. ' '2021;384(16):1564–5.', 'journal-title': 'N Engl J Med'}, { 'issue': '1', 'key': '543_CR14', 'doi-asserted-by': 'publisher', 'first-page': '794', 'DOI': '10.1186/s13063-020-04633-3', 'volume': '21', 'author': 'AF Caballero Bermejo', 'year': '2020', 'unstructured': 'Caballero Bermejo AF, Ruiz-Antorán B, Cruz AF, Sempere ED, Díaz AC, ' 'Rubio EM, et al. Sarilumab versus standard of care for the early ' 'treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a ' 'structured summary of a study protocol for a randomised controlled ' 'trial. Trials. 2020;21(1):794.', 'journal-title': 'Trials'}, { 'issue': '8', 'key': '543_CR15', 'doi-asserted-by': 'publisher', 'first-page': '693', 'DOI': '10.1056/NEJMoa2021436', 'volume': '384', 'author': 'RECOVERY Collaborative Group', 'year': '2021', 'unstructured': 'RECOVERY Collaborative Group. Dexamethasone in hospitalized patients ' 'with Covid-19. N Engl J Med. 2021;384(8):693–704. ' 'https://doi.org/10.1056/NEJMoa2021436.', 'journal-title': 'N Engl J Med'}, { 'issue': '5 Suppl', 'key': '543_CR16', 'first-page': 'CD1', 'volume': '22', 'author': 'A Duca', 'year': '2020', 'unstructured': 'Duca A, Piva S, Focà E, Latronico N, Rizzi M. Calculated decisions: ' 'Brescia-COVID Respiratory Severity Scale (BCRSS)/algorithm. Emerg Med ' 'Pract. 2020;22(5 Suppl):CD1-2.', 'journal-title': 'Emerg Med Pract'}, { 'issue': '16', 'key': '543_CR17', 'doi-asserted-by': 'publisher', 'first-page': '1503', 'DOI': '10.1056/NEJMoa2028700', 'volume': '384', 'author': 'IO Rosas', 'year': '2021', 'unstructured': 'Rosas IO, Bräu N, Waters M, Go RC, Hunter BD, Bhagani S, et al. ' 'Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N ' 'Engl J Med. 2021;384(16):1503–16. https://doi.org/10.1056/NEJMoa2028700.', 'journal-title': 'N Engl J Med'}, { 'issue': '5', 'key': '543_CR18', 'doi-asserted-by': 'publisher', 'first-page': '522', 'DOI': '10.1016/S2213-2600(21)00099-0', 'volume': '9', 'author': 'F-X Lescure', 'year': '2021', 'unstructured': 'Lescure F-X, Honda H, Fowler RA, Lazar JS, Shi G, Wung P, et al. ' 'Sarilumab in patients admitted to hospital with severe or critical ' 'COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial. ' 'Lancet Respir Med. 2021;9(5):522–32.', 'journal-title': 'Lancet Respir Med'}, { 'key': '543_CR19', 'doi-asserted-by': 'publisher', 'DOI': '10.1056/NEJMoa2028836', 'author': 'JH Stone', 'year': '2020', 'unstructured': 'Stone JH, Frigault MJ, Serling-Boyd NJ, Fernandes AD, Harvey L, Foulkes ' 'AS, et al. Efficacy of tocilizumab in patients hospitalized with ' 'Covid-19. N Engl J Med. 2020. https://doi.org/10.1056/NEJMoa2028836.', 'journal-title': 'N Engl J Med'}, { 'key': '543_CR20', 'doi-asserted-by': 'publisher', 'DOI': '10.1136/bmj.n84', 'author': 'VC Veiga', 'year': '2019', 'unstructured': 'Veiga VC, Prats JAGG, Farias DLC, Rosa RG, Dourado LK, Zampieri FG, et ' 'al. Effect of tocilizumab on clinical outcomes at 15 days in patients ' 'with severe or critical coronavirus disease 2019: randomised controlled ' 'trial. BMJ. 2019. https://doi.org/10.1136/bmj.n84.', 'journal-title': 'BMJ'}, { 'issue': '1', 'key': '543_CR21', 'doi-asserted-by': 'publisher', 'first-page': '20', 'DOI': '10.1056/NEJMoa2030340', 'volume': '384', 'author': 'C Salama', 'year': '2021', 'unstructured': 'Salama C, Han J, Yau L, Reiss WG, Kramer B, Neidhart JD, et al. ' 'Tocilizumab in patients hospitalized with Covid-19 pneumonia. N Engl J ' 'Med. 2021;384(1):20–30. https://doi.org/10.1056/NEJMoa2030340.', 'journal-title': 'N Engl J Med'}, { 'issue': '1', 'key': '543_CR22', 'doi-asserted-by': 'publisher', 'first-page': '32', 'DOI': '10.1001/jamainternmed.2020.6820', 'volume': '181', 'author': 'O Hermine', 'year': '2021', 'unstructured': 'Hermine O, Mariette X, Tharaux P-L, Resche-Rigon M, Porcher R, Ravaud P, ' 'et al. Effect of tocilizumab vs usual care in adults hospitalized with ' 'COVID-19 and moderate or severe pneumonia. JAMA Intern Med. ' '2021;181(1):32.', 'journal-title': 'JAMA Intern Med'}], 'container-title': 'Infectious Diseases and Therapy', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40121-021-00543-2.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s40121-021-00543-2/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s40121-021-00543-2.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2021, 11, 7]], 'date-time': '2021-11-07T14:18:33Z', 'timestamp': 1636294713000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s40121-021-00543-2'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 10, 17]]}, 'references-count': 22, 'journal-issue': {'issue': '4', 'published-print': {'date-parts': [[2021, 12]]}}, 'alternative-id': ['543'], 'URL': 'http://dx.doi.org/10.1007/s40121-021-00543-2', 'relation': {}, 'ISSN': ['2193-8229', '2193-6382'], 'subject': [], 'container-title-short': 'Infect Dis Ther', 'published': {'date-parts': [[2021, 10, 17]]}, 'assertion': [ { 'value': '5 September 2021', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '27 September 2021', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '17 October 2021', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}]}
Late treatment
is less effective
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit